First clinical trial of the COVID-19 vaccine in the US, success - GazeFeed


First clinical trial of the COVID-19 vaccine in the US, success - GazeFeed


An American company reported that the phase 1 clinical trial conducted on the experimental vaccine against COVID-19 was positive.

According to US biotech company Moderna on Channel News Asia, the eight volunteers received an mRNA-1273 vaccine, similar to that seen in patients who had contracted the virus, an “immune response” against COVID-19.

At the same time, the company has announced phase 3 trials beginning in July where a larger number of volunteers will be appointed.

The phase 3 trial, the latest and most important phase, will prove the effectiveness of the vaccine against the virus.

The National Institutes of Health conducts the clinical test.

The US government has allocated half a billion dollars for Moderna vaccine development.

Engage with us via comment or if you have some business proposals or collaborations you can send it here in our official email: gazefeeddotcom@gmail.com

via | GazeFeed

Post a Comment

0 Comments